Brief: Dri Healthcare Trust Says Approval Of Pacritinib By FDA Is Condition To Acquisition Of Tiered Royalty On Pacritinib
30/11/2021 23:40
Nov 30 (Reuters) - CTI Biopharma Corp CTIC.O :
* DRI HEALTHCARE TRUST - APPROVAL OF PACRITINIB BY FDA IS
CONDITION TO ACQUISITION OF TIERED ROYALTY ON PACRITINIB, AS
ANNOUNCED ON AUGUST 25, 2021
Source text for Eikon: ID:nCNW5QW0Za
Further company coverage: CTIC.O
Recent news on CTI Biopharma
See all newsBrief: CTI Biopharma Cancels 2023 Annual Meeting Of Stockholders
U.S. RESEARCH ROUNDUP-Albemarle, Ellington Financial, Savara
U.S. RESEARCH ROUNDUP-CTI Biopharma, Park National, Playags
U.S. STOCKS ON THE MOVE-First Citizens BancShares, Sarepta, Celsius Holdings
U.S. STOCKS ON THE MOVE-Taboola, US banks, Copper miners